27 Mar COVID-19 and Continuity of Supply in Australia
MetaGene has been monitoring developments with regards to the novel coronavirus (COVID-19), specifically with regards to continuing the supply of products to our customers. We are working closely with our overseas manufacturers, including Biocare Medical, Horizon Discovery and Santa Cruz Biotechnology, as well as supply chain partners including FEDEX and StarTrack to ensure continuity of supply, however, this is an unprecedented and dynamic situation.
In the short term, we do not anticipate supply chain disruption.
We reserve the right to limit order quantities based on demand so that we can ensure supply chain continuity for products used in clinical patient testing. As the situation evolves, we will endeavour to communicate relevant changes as soon as possible.